SHE/300244 (SHE/300244)

Shenzhen Stock Exchange: SHE/300244 · CNY

CN¥21.4

+1.19 (+5.9%)· Recorded snapshot

Market cap	13.1B
Revenue (ttm)	9.9B
Net income (ttm)	469.5M
EPS (ttm)	CN¥0.77
Shares out	611.1M
P/E (trailing)	27.9x
P/E (forward)	28.4x
Dividend	CN¥0.35 (1.63%)
Volume	55,895,470
Beta	0.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.9B
Net income (ttm): 469.5M
EPS (ttm): CN¥0.77
P/E (trailing): 27.9x
P/E (forward): 28.4x
Market cap: 13.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.4

P25 n/aP50 n/aP75 n/a

Trailing P/E27.9

P25 n/aP50 n/aP75 n/a

ROE6.8

P25 n/aP50 n/aP75 n/a

ROIC8.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All SHE/300244 indicators

Market & fundamental data

Available fields

256

Groups with data

Currency

CNY

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-20
Employees	7,462
Employees change	-1,311
Employees growth	-14.94%
Enterprise value	CNY 15.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Diagnostics & Research
Is primary listing	Yes
ISIN number	CNE1000015N1
Last earnings date	2026-10-20
Last refreshed	2026-10-28
Last stock split date	2016-05-09
Last stock split type	Forward
Market cap	CNY 13.1B
Next earnings date	2026-10-30
Price	CNY 21.44
Price currency	CNY
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	she/300244
Website	https://www.dazd.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	102.05x
Average P/E ratio (5Y)	204.39x
Earnings yield	3.58%
EV/Earnings	32.42x
EV/EBIT	15.4x
EV/EBITDA	11.29x
EV/FCF	8.79x
EV/Sales	1.53x
FCF / EV yield	11.37%
FCF yield	13.22%
Forward P/E	28.4x
Graham number	13.78942
Graham upside	-35.68%
Industry forward P/E	17.56x
Industry P/E	21.59x
Lynch fair value	CNY 3.84
Lynch upside	-82.08%
P/B ratio	1.48x
P/E ratio	27.9x
P/FCF ratio	7.57x
P/OCF ratio	6.61x
P/S ratio	1.32x
Price / tangible book value	2.16x
Price/EBITDA ratio	11x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.95%
EBITDA margin	11.98%
Effective tax rate	25.15%
FCF margin	17.42%
Gross margin	29.07%
Operating margin	9.95%
Pretax margin	7.99%
Profit margin	4.72%
Profit per employee	CNY 62,918
Profitable quarters	3
Profitable years	1
Revenue per employee	CNY 1.3M
ROA	4.34%
ROA (5Y)	5.86%
ROCE	9.8%
ROE	6.79%
ROE (5Y)	9.95%
ROIC	8.36%
ROIC (5Y)	12.66%
Tax / revenue	2.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	436.85%
EPS growth (QoQ)	48.69%
EPS growth 10Y	5.48%
EPS growth 5Y	-15.7%
EPS growth quarters	4
EPS growth years	1
FCF growth	3.6%
FCF growth (Q)	-4.69%
FCF growth (QoQ)	49.92%
FCF growth 3Y	17.58%
FCF growth 5Y	10.53%
Gross profit growth	-3.28%
Gross profit growth (Q)	-2.06%
Gross profit growth 3Y	-13.23%
Gross profit growth 5Y	-9.88%
Net income growth (Q)	438.03%
Net income growth (QoQ)	48.7%
Net income growth 5Y	-16.2%
Net income growth quarters	4
Net income growth years	1
OCF growth	-2.18%
OCF growth (Q)	-4.93%
OCF growth (QoQ)	33.47%
OCF growth 10Y	40.37%
OCF growth 3Y	0.46%
OCF growth 5Y	4.49%
Operating income growth	217.18%
Operating income growth (Q)	74.29%
Operating income growth 3Y	-6.89%
Operating income growth 5Y	-15.9%
Revenue growth	-5.38%
Revenue growth (Q)	0.23%
Revenue growth (QoQ)	4.31%
Revenue growth 10Y	12.19%
Revenue growth 3Y	-12.71%
Revenue growth 5Y	-4.5%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -249.2M
Depreciation and amortization	CNY 202.4M
EBIT	CNY 988.8M
EBITDA	CNY 1.2B
EPS	CNY 0.77
FCF per share	CNY 2.83
Financing cash flow	CNY -2B
Free cash flow	CNY 1.7B
Gross profit	CNY 2.9B
Income taxes	CNY 199.8M
Investing cash flow	CNY -348.7M
Net borrowing	CNY -1.5B
Net cash flow	CNY -393M
Net income	CNY 469.5M
Operating income	CNY 988.8M
Revenue	CNY 9.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.4
Book value per share	CNY 11.00
Debt / EBITDA	1.14
Debt / equity	0.17
Debt / FCF	0.88
Goodwill	CNY 598.4M
Interest coverage	6.92
Long-term assets	CNY 3.6B
Long-term liabilities	CNY 1.2B
Net cash (debt)	CNY -3.9M
Net cash / market cap	-0.03%
Net debt / EBITDA	0
Net debt / equity	0
Net debt / FCF	0
Piotroski F-Score	8
Property, plant and equipment	CNY 1.3B
Shareholders' equity	CNY 8.8B
Tangible book value	CNY 6.1B
Tangible book value per share	CNY 9.91
Total assets	CNY 13.7B
Total cash	CNY 1.5B
Total debt	CNY 1.5B
Total liabilities	CNY 4.9B
WACC	7.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.7
Current assets	CNY 10.1B
Current liabilities	CNY 3.6B
Current ratio	2.77
Inventory turnover	4.6
Net working capital	CNY 5.8B
Quick ratio	2.22
Working capital	CNY 6.4B
Working capital turnover	1.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.15%
Dividend growth	-61.11%
Dividend growth (10Y)	13.35%
Dividend growth (3Y)	20.51%
Dividend growth (5Y)	21.91%
Dividend growth years	0
Dividend payment date	2026-06-25
Dividend payment years	15
Dividend payout frequency	Annual
Dividend per share	CNY 0.35
Dividend yield	1.63%
Ex-dividend date	2026-06-25
FCF payout ratio	12.35%
Last dividend	CNY 0.35
Payout ratio	61.21%
Shareholder yield	1.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-34.63%
10Y return CAGR	-2.89%
10Y total return	-25.4%
150-day SMA	CNY 19.04
15Y price change	364.98%
15Y return CAGR	11.87%
15Y total return	438.21%
1D price change	5.88%
1M price change	3.13%
1M total return	3.13%
1W price change	-1.61%
1W total return	-1.61%
1Y price change	35.95%
1Y return CAGR	38.52%
1Y total return	38.49%
20-day SMA	CNY 20.52
200-day SMA	CNY 19.95
3M price change	30.41%
3M total return	30.41%
3Y price change	-4.37%
3Y return CAGR	2.19%
3Y total return	6.71%
50-day SMA	CNY 19.65
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 33.30
52-week high date	2026-01-14
52-week low	CNY 14.48
52-week low date	2025-12-16
5Y price change	-33.77%
5Y return CAGR	-5.64%
5Y total return	-25.2%
6M price change	13.14%
6M total return	15.25%
All-time high	CNY 86.97
All-time high date	2015-06-05
All-time low	CNY 3.55
All-time low date	2012-01-19
Average true range (ATR)	CNY 1.37
Average volume	45.2M
Beta (1Y)	0.84
Beta (2Y)	1.13
Beta (5Y)	0.69
Change from 52-week high	-35.62%
Change from 52-week low	48.07%
Change from all-time high	-75.35%
Change from all-time low	504.62%
Change from open	2.68%
Day's gap	3.11%
Dollar volume	CNY 1.2B
High price	CNY 21.63
Low price	CNY 20.25
Monthly RSI	56.92
Open price	CNY 20.88
Position in 52-week range	86.23%
Previous close	CNY 20.25
Price vs 150-day SMA	12.59%
Price vs 20-day SMA	4.49%
Price vs 200-day SMA	7.47%
Price vs 50-day SMA	9.13%
Relative volume	1.25
RSI	55.94
Sharpe ratio	0.79
Sharpe ratio (3Y)	0.24
Sharpe ratio (5Y)	0.02
Sortino ratio	1.55
Sortino ratio (3Y)	0.53
Sortino ratio (5Y)	0.17
Volume	55.9M
Weekly RSI	55.89
YTD price change	35.27%
YTD total return	37.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	434.6M
Shares change (QoQ)	0.01%
Shares change (YoY)	-0.15%
Shares held by insiders	27.14%
Shares held by institutions	10.47%
Shares outstanding	611.1M

Deeper analysis on SHE/300244

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this SHE/300244 report

Is a complete SHE/300244 research report available?

No complete published report is available for she/300244 (SHE/300244) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

13.1B

Revenue (ttm)

9.9B

Net income (ttm)

469.5M

EPS (ttm)

CN¥0.77

Shares out

611.1M

P/E (trailing)

27.9x

P/E (forward)

28.4x

Dividend

CN¥0.35 (1.63%)

Volume

55,895,470

Beta

0.69

Metric

Value

Amount currency

CNY

Country

China

Country code

Earnings date

2026-10-20

Employees

7,462

Employees change

-1,311

Employees growth

-14.94%

Enterprise value

CNY 15.2B

Exchange

Shenzhen Stock Exchange

Financial currency

CNY

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1996

Industry

Diagnostics & Research

Is primary listing

Yes

ISIN number

CNE1000015N1

Last earnings date

2026-10-20

Last refreshed

2026-10-28

Last stock split date

2016-05-09

Last stock split type

Forward

Market cap

CNY 13.1B

Next earnings date

2026-10-30

Price

CNY 21.44

Price currency

CNY

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

she/300244

Website

https://www.dazd.cn

Metric

Value

Average P/E ratio (10Y)

102.05x

Average P/E ratio (5Y)

204.39x

Earnings yield

3.58%

EV/Earnings

32.42x

EV/EBIT

15.4x

EV/EBITDA

11.29x

EV/FCF

8.79x

EV/Sales

1.53x

FCF / EV yield

11.37%

FCF yield

13.22%

Forward P/E

28.4x

Graham number

13.78942

Graham upside

-35.68%

Industry forward P/E

17.56x

Industry P/E

21.59x

Lynch fair value

CNY 3.84

Lynch upside

-82.08%

P/B ratio

1.48x

P/E ratio

27.9x

P/FCF ratio

7.57x

P/OCF ratio

6.61x

P/S ratio

1.32x

Price / tangible book value

2.16x

Price/EBITDA ratio

11x

Sector forward P/E

20.65x

Sector P/E

37.05x

Metric

Value

EBIT margin

9.95%

EBITDA margin

11.98%

Effective tax rate

25.15%

FCF margin

17.42%

Gross margin

29.07%

Operating margin

9.95%

Pretax margin

7.99%

Profit margin

4.72%

Profit per employee

CNY 62,918

Profitable quarters

Profitable years

Revenue per employee

CNY 1.3M

ROA

4.34%

ROA (5Y)

5.86%

ROCE

9.8%

ROE

6.79%

ROE (5Y)

9.95%

ROIC

8.36%

ROIC (5Y)

12.66%

Tax / revenue

2.01%

Metric

Value

EPS growth (Q)

436.85%

EPS growth (QoQ)

48.69%

EPS growth 10Y

5.48%

EPS growth 5Y

-15.7%

EPS growth quarters

EPS growth years

FCF growth

3.6%

FCF growth (Q)

-4.69%

FCF growth (QoQ)

49.92%

FCF growth 3Y

17.58%

FCF growth 5Y

10.53%

Gross profit growth

-3.28%

Gross profit growth (Q)

-2.06%

Gross profit growth 3Y

-13.23%

Gross profit growth 5Y

-9.88%

Net income growth (Q)

438.03%

Net income growth (QoQ)

48.7%

Net income growth 5Y

-16.2%

Net income growth quarters

Net income growth years

OCF growth

-2.18%

OCF growth (Q)

-4.93%

OCF growth (QoQ)

33.47%

OCF growth 10Y

40.37%

OCF growth 3Y

0.46%

OCF growth 5Y

4.49%

Operating income growth

217.18%

Operating income growth (Q)

74.29%

Operating income growth 3Y

-6.89%

Operating income growth 5Y

-15.9%

Revenue growth

-5.38%

Revenue growth (Q)

0.23%

Revenue growth (QoQ)

4.31%

Revenue growth 10Y

12.19%

Revenue growth 3Y

-12.71%

Revenue growth 5Y

-4.5%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

CNY -249.2M

Depreciation and amortization

CNY 202.4M

EBIT

CNY 988.8M

EBITDA

CNY 1.2B

EPS

CNY 0.77

FCF per share

CNY 2.83

Financing cash flow

CNY -2B

Free cash flow

CNY 1.7B

Gross profit

CNY 2.9B

Income taxes

CNY 199.8M

Investing cash flow

CNY -348.7M

Net borrowing

CNY -1.5B

Net cash flow

CNY -393M

Net income

CNY 469.5M

Operating income

CNY 988.8M

Revenue

CNY 9.9B

Metric

Value

Altman Z-Score

3.4

Book value per share

CNY 11.00

Debt / EBITDA

1.14

Debt / equity

0.17

Debt / FCF

0.88

Goodwill

CNY 598.4M

Interest coverage

6.92

Long-term assets

CNY 3.6B

Long-term liabilities

CNY 1.2B

Net cash (debt)

CNY -3.9M

Net cash / market cap

-0.03%

Net debt / EBITDA

Net debt / equity

Net debt / FCF

Piotroski F-Score

Property, plant and equipment

CNY 1.3B

Shareholders' equity

CNY 8.8B

Tangible book value

CNY 6.1B

Tangible book value per share

CNY 9.91

Total assets

CNY 13.7B

Total cash

CNY 1.5B

Total debt

CNY 1.5B

Total liabilities

CNY 4.9B

WACC

7.95%

Metric

Value

Asset turnover

0.7

Current assets

CNY 10.1B

Current liabilities

CNY 3.6B

Current ratio

2.77

Inventory turnover

4.6

Net working capital

CNY 5.8B

Quick ratio

2.22

Working capital

CNY 6.4B

Working capital turnover

1.48

Metric

Value

Buyback yield / dilution

0.15%

Dividend growth

-61.11%

Dividend growth (10Y)

13.35%

Dividend growth (3Y)

20.51%

Dividend growth (5Y)

21.91%

Dividend growth years

Dividend payment date

2026-06-25

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

CNY 0.35

Dividend yield

1.63%

Ex-dividend date

2026-06-25

FCF payout ratio

12.35%

Last dividend

CNY 0.35

Payout ratio

61.21%

Shareholder yield

1.79%

Metric

Value

10Y price change

-34.63%

10Y return CAGR

-2.89%

10Y total return

-25.4%

150-day SMA

CNY 19.04

15Y price change

364.98%

15Y return CAGR

11.87%

15Y total return

438.21%

1D price change

5.88%

1M price change

3.13%

1M total return

3.13%

1W price change

-1.61%

1W total return

-1.61%

1Y price change

35.95%

1Y return CAGR

38.52%

1Y total return

38.49%

20-day SMA

CNY 20.52

200-day SMA

CNY 19.95

3M price change

30.41%

3M total return

30.41%

3Y price change

-4.37%

3Y return CAGR

2.19%

3Y total return

6.71%

50-day SMA

CNY 19.65

50-day SMA vs 200-day SMA

50under200

52-week high

CNY 33.30

52-week high date

2026-01-14

52-week low

CNY 14.48

52-week low date

2025-12-16

5Y price change

-33.77%

5Y return CAGR

-5.64%

5Y total return

-25.2%

6M price change

13.14%

6M total return

15.25%

All-time high

CNY 86.97

All-time high date

2015-06-05

All-time low

CNY 3.55

All-time low date

2012-01-19

Average true range (ATR)

CNY 1.37

Average volume

45.2M

Beta (1Y)

0.84

Beta (2Y)

1.13

Beta (5Y)

0.69

Change from 52-week high

-35.62%

Change from 52-week low

48.07%

Change from all-time high

-75.35%

Change from all-time low

504.62%

Change from open

2.68%

Day's gap

3.11%

Dollar volume

CNY 1.2B

High price

CNY 21.63

Low price

CNY 20.25

Monthly RSI

56.92

Open price

CNY 20.88

Position in 52-week range

86.23%

Previous close

CNY 20.25

Price vs 150-day SMA

12.59%

Price vs 20-day SMA

4.49%

Price vs 200-day SMA

7.47%

Price vs 50-day SMA

9.13%

Relative volume

1.25

RSI

55.94

Sharpe ratio

0.79

Sharpe ratio (3Y)

0.24

Sharpe ratio (5Y)

0.02

Sortino ratio

1.55

Sortino ratio (3Y)

0.53

Sortino ratio (5Y)

0.17

Volume

55.9M

Weekly RSI

55.89

YTD price change

35.27%

YTD total return

37.79%

Metric

Value

Float

434.6M

Shares change (QoQ)

0.01%

Shares change (YoY)

-0.15%

Shares held by insiders

27.14%

Shares held by institutions

10.47%

Shares outstanding

611.1M

SHE/300244 (SHE/300244)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300244

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300244 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300244

Frequently asked questions

SHE/300244 (SHE/300244)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300244

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300244 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300244

Frequently asked questions